Lovastatin, a common statin usually prescribed to control cholesterol, corrected learning and memory deficits associated with Fragile X syndrome in rodent models.
The common statin drug Simvastatin reduces brain atrophy and slows the progression of secondary progressive multiple sclerosis (SPMS). The effects appear to be independent of the drug's cholesterol-lowering effects.
Study reveals there is no link between memory decline and statin use in older adults. Additionally, no association was found between statin use and cognitive decline in those with genetic risk factors for dementia.
According to a comprehensive systematic review, available evidence does not support an association between statins and cognitive decline.
Researchers have found a link between a commonly prescribed statin drug and cognitive impairment, according to a new study.
A new study reports statins may reverse learning deficits caused by a genetic mutation in Noonan syndrome.
Adding icosapent ethyl, a triglyceride-lowering medication that is high in the omega 3 fatty acid, eicosapentaenoic acid, in combination with statins helped to reduce stroke risk by 36% in those with cardiovascular disease.
A new study reports statins can protect blood vessels from a substance that causes inflammation.